PFIZER LTD.
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹3810
- Today's High:
- ₹3889.8
- Open Price:
- ₹3848.55
- 52W Low:
- ₹3406.95
- 52W High:
- ₹4662.3501
- Prev. Close:
- ₹3846.6499
- Volume:
- 3909
Company Statistics
- Market Cap.:
- ₹175.83 billion
- Book Value:
- 468.13
- Revenue TTM:
- ₹21.50 billion
- Operating Margin TTM:
- 24.91%
- Gross Profit TTM:
- ₹13.53 billion
- Profit Margin:
- 23.15%
- Return on Assets TTM:
- 9.32%
- Return on Equity TTM:
- 18.8%
Company Profile
PFIZER LTD. had its IPO on under the ticker symbol PFIZER.
The company operates in the Healthcare sector and Pharmaceuticals industry. PFIZER LTD. has a staff strength of 2,489 employees.
Stock update
Shares of PFIZER LTD. opened at ₹3848.55 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹3810 - ₹3889.8, and closed at ₹3837.5.
This is a -0.24% slip from the previous day's closing price.
A total volume of 3,909 shares were traded at the close of the day’s session.
In the last one week, shares of PFIZER LTD. have slipped by -0.46%.
PFIZER LTD.'s Key Ratios
PFIZER LTD. has a market cap of ₹175.83 billion, indicating a price to book ratio of 6.8762 and a price to sales ratio of 8.1666.
In the last 12-months PFIZER LTD.’s revenue was ₹21.50 billion with a gross profit of ₹13.53 billion and an EBITDA of ₹6.05 billion. The EBITDA ratio measures PFIZER LTD.'s overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, PFIZER LTD.’s operating margin was 24.91% while its return on assets stood at 9.32% with a return of equity of 18.8%.
In Q4, PFIZER LTD.’s quarterly earnings growth was a negative -14.9% while revenue growth was a positive 5%.
PFIZER LTD.’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 33.7461
- PEG
Its diluted EPS in the last 12-months stands at ₹108.825 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into PFIZER LTD.’s profitability.
PFIZER LTD. stock is trading at a EV to sales ratio of 7.6041 and a EV to EBITDA ratio of 20.42. Its price to sales ratio in the trailing 12-months stood at 8.1666.
PFIZER LTD. stock pays annual dividends of ₹10 per share, indicating a yield of 0.26% and a payout ratio of 60.16%.
Balance sheet and cash flow metrics
- Total Assets
- ₹38.31 billion
- Total Liabilities
- ₹7.64 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 60.16%
PFIZER LTD. ended 2024 with ₹38.31 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹38.31 billion while shareholder equity stood at ₹29.16 billion.
PFIZER LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹7.64 billion in other current liabilities, 457500000.00 in common stock, ₹28.70 billion in retained earnings and ₹5.27 billion in goodwill. Its cash balance stood at ₹941.80 million and cash and short-term investments were ₹16.23 billion. The company’s total short-term debt was ₹25,000,000 while long-term debt stood at ₹0.
PFIZER LTD.’s total current assets stands at ₹23.45 billion while long-term investments were ₹0 and short-term investments were ₹603.20 million. Its net receivables were ₹1.58 billion compared to accounts payable of ₹1.95 billion and inventory worth ₹4.57 billion.
In 2024, PFIZER LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, PFIZER LTD. paid ₹0.60 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹3837.5
- 52-Week High
- ₹4662.3501
- 52-Week Low
- ₹3406.95
- Analyst Target Price
- ₹
PFIZER LTD. stock is currently trading at ₹3837.5 per share. It touched a 52-week high of ₹4662.3501 and a 52-week low of ₹4662.3501. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹3873.72 and 200-day moving average was ₹3927.64 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 6601.9% of the company’s stock are held by insiders while 1520.2% are held by institutions.
Frequently Asked Questions About PFIZER LTD.
Similar Industry Stocks (Pharmaceuticals)
Most Active
Top Gainers
Top Losers
About
Pfizer Limited manufactures, markets, trades in, and exports pharmaceutical products in India and internationally. It offers its various products in various therapeutic areas, including anti-allergic, anti-diabetic, antihistamine, anti-infective, anti-parasitic, cardiovascular, dermatology, erectile dysfunction, neurology, pain/fever/inflammation, pediatrics, psychiatry, respiratory, urology, women’s health, central nervous system, autoimmune disorders, and gastrointestinal. The company also provides multivitamins, vitamins/minerals, antibiotics, steroids, vaccines, and consumer healthcare products. It sells its products through a network of independent distributors primarily under the Minipress XL, Folvite, Magnex, Eliquis, Gelusil, Lyrica, Ovral L, Citralka, Prevenar 13, Autrin, Zavicefta, Wysolone, Xeljanz, Corex, Mucaine, Becosules, Ativan, Neksium, Meronem, And Dolonex brand names. Pfizer Limited was incorporated in 1950 and is headquartered in Mumbai, India.